Current Liabilities: The sum of all liabilities classified as current for having maturities of less than one year.
Castle Biosciences, Inc. (CSTL) had Current Liabilities of $50.89M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$86.19M |
|
$4.52M |
|
$17.63M |
|
$68.56M |
|
$90.44M |
|
$-4.25M |
|
$4.11M |
|
$-0.14M |
|
$-0.14M |
|
$4.52M |
|
$4.52M |
|
$4.52M |
|
$4.52M |
|
$-4.25M |
|
$-2.01M |
|
28.91M |
|
29.55M |
|
$0.16 |
|
$0.15 |
|
| Balance Sheet Financials | |
$348.67M |
|
$74.06M |
|
$196.06M |
|
$544.73M |
|
|
Current Liabilities |
$50.89M |
$8.46M |
|
$38.46M |
|
$89.35M |
|
$455.38M |
|
$351.25M |
|
$455.38M |
|
28.98M |
|
| Cash Flow Statement Financials | |
$14.79M |
|
$-50.81M |
|
$-1.45M |
|
$119.71M |
|
$82.23M |
|
$-37.48M |
|
$22.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.85 |
|
-- |
|
-- |
|
0.02 |
|
0.02 |
|
79.55% |
|
-4.93% |
|
-4.93% |
|
-- |
|
-0.17% |
|
5.25% |
|
$0.80M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
2.11 |
|
1.65 |
|
54.62 |
|
0.99% |
|
1.29% |
|
0.83% |
|
0.98% |
|
$15.71 |
|
$0.03 |
|
$0.50 |
|